🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for PSA

Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy NCT06450106Phase 14 sites📍 Tucson📍 Gainesville📍 Melbourne N. SURGE Therapeutics · Tests: STM-416p Imperial Prostate 7 - Prostate Assessment Using Comparative Interventions - Fast Mri and Image-fusion for Cancer NCT05574647NA15 sites📍 Southend-on-Sea📍 Southampton📍 Gillingham Imperial College London · Tests: bpMRI, Image-Fusion targeted and systematic Biopsy Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test NCT05629494Phase 43 sites📍 Chicago📍 Albany📍 Hershey Albany Medical College · Tests: Ibuprofen 400 mg, TID, PSA test Phase II Trial of PSA Response-based Androgen Deprivation Therapy and Nodal Coverage for Prostate Cancer Early Salvage Radiotherapy (RANGER) NCT07313241Phase 21 site📍 Dallas University of Texas Southwestern Medical Center · Tests: Prostate Fossa Radiotherapy, Pelvic nodal Radiotherapy, Androgen Deprivation Therapy (ADT) MRI-Assisted Guidance for Non-Essential Tissue Sampling NCT07516223NA1 site📍 Shanghai Shanghai East Hospital · Tests: Paired Prostate Biopsy Cohort (TB + SB) Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA NCT06600698Phase 1, Phase 21 site📍 Hershey Milton S. Hershey Medical Center · Tests: INM176 Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis NCT07443956NA4 sites📍 Birmingham📍 Coventry📍 Newcastle upon Tyne NHS Greater Glasgow and Clyde · Tests: Ixekizumab, Tirzepatide Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response NCT06592924Phase 3395 sites📍 Anchorage📍 Anchorage📍 Anchorage Canadian Cancer Trials Group · Tests: Abiraterone, Enzalutamide, Apalutamide, Darolutamide (BAY 1841788), Docetaxel EDRN Prostate MRI Biomarker Study NCT03784924n/a1 site📍 Ann Arbor University of Michigan · Tests: MRI prostate Physician- vs Questionnaire-Based Screening for Psoriatic Arthritis in Psoriasis NCT07298265n/a1 site📍 Toronto Charite University, Berlin, Germany Evaluation of an MRI-based Prostate Cancer Screening Program (VISIONING): 5-Year Follow-up Round (VISIONING III) NCT07762911NA1 site📍 Basel University Hospital, Basel, Switzerland · Tests: MRI Multicenter Assessment of Clinical Utility PET / MR With the Use of the Radiotracer 68Ga-PSMA-11 in Therapy Planning Personalized in Patients With Prostate Cancer NCT05582876NA7 sites📍 Bialystok📍 Bialystok📍 Bialystok Medical University of Bialystok · Tests: Radiopharmaceutical 68Ga-PSMA-11 PET/CT Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy NCT05295407n/a1 site📍 Evanston Endeavor Health · Tests: Genetic Assessment Optimal PSA Triggered Individual Management of Androgen Sensitive Prostate Cancer NCT07216248Phase 21 site📍 Salt Lake City University of Utah · Tests: relugolix + ARPI, Intermittent- Relugolix or androgen deprivation therapy (ADT) + ARPI, relugolix or androgen deprivati… Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer NCT04692675NA1 site📍 Bethesda National Cancer Institute (NCI) · Tests: mpMRI Safety and Exploratory Efficacy of Transplantation Therapy Using PSA-NCAM(+) NPC in AIS-A Level of Sub-acute SCI NCT04812431Phase 1, Phase 22 sites📍 Suwon📍 Seoul S.Biomedics Co., Ltd. · Tests: Neural precursor cells derived from human embryonic stem cell line Sleep More, Stress Less: 90-Day Trial of Neuralli Mood NCT07717385NA1 site📍 New York Efforia, Inc · Tests: Neuralli Mood A Study of Guselkumab in Participants With Psoriatic Arthritis (PsA) in a Real-World Setting NCT07220824n/a21 sites📍 Bari📍 Brescia📍 Iesi Janssen Research & Development, LLC Oxidative Stress in Autoimmune Rheumatic Diseases NCT07536529n/a1 site📍 Larissa University of Thessaly Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis NCT07286058Phase 378 sites📍 Tucson📍 Fountain Valley📍 La Mesa Takeda · Tests: Zasocitinib MRI/Ultrasound Fusion Guided Prostate Cryotherapy NCT02381990n/a1 site📍 Miami Lakes Urological Research Network, LLC · Tests: FUSE IMAGE MRI GUIDED PROSTATE CRYOTHERAPY A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab) NCT06888193Phase 114 sites📍 Santa Monica📍 South Miami📍 Boston UCB Biopharma SRL · Tests: Bimekizumab Upright MRI for Prostate Cancer Screening NCT03474913n/a1 site📍 New York Icahn School of Medicine at Mount Sinai · Tests: Upright MRI, Standard MRI Trans and Non-binary Prostate-Specific Antigen Reference Interval Determination Study NCT06987045n/a1 site📍 London Queen Mary University of London PSA Biochemical Response as Prognostic Factor in Metastatic Castration-Sensitive Prostate Cancer NCT06652607n/a1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: Enzalutamide, Apalutamide (Erleada™) 60 mg or 240 mg tablets, Darolutamide (Nubeqa®) 300 mg tablets, Taxotere (docetaxe… Sex and Gender-based Analysis of the Effectiveness of Advanced Therapies in Psoriatic Arthritis NCT05954364n/a1 site📍 Toronto Women's College Hospital Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research NCT04806620n/a1 site📍 Delafield Brain Inflammation Collaborative Determination of Prostate-specific Antigen in Capillary Blood (PSA-Cap) NCT06626386n/a1 site📍 Düsseldorf Heinrich-Heine University, Duesseldorf · Tests: PSA testing IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy NCT07686380Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: N-803, ETBX-71 Vaccine, 18F-DCFPyL Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease NCT07280702Phase 41 site📍 Dallas University of Texas Southwestern Medical Center · Tests: Deucravacitinib, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy